Ligand Pharmaceuticals, Inc. (LGND)
181.46
-4.50
(-2.42%)
USD |
NASDAQ |
Feb 12, 16:00
181.89
+0.43
(+0.24%)
Pre-Market: 20:00
Ligand Pharmaceuticals Free Cash Flow : 20.43M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Merck & Co., Inc. | 13.05B |
| Johnson & Johnson | 19.70B |
| Elanco Animal Health, Inc. | 362.00M |
| Ionis Pharmaceuticals, Inc. | -309.48M |
| Krystal Biotech, Inc. | 165.59M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 13.16M |
| Cash from Investing (Quarterly) | -353.44M |
| Cash from Financing (Quarterly) | 409.57M |
| Free Cash Flow Per Share (Quarterly) | 0.2306 |
| Free Cash Flow to Equity (Quarterly) | -440.50M |
| Free Cash Flow to Firm (Quarterly) | 5.513M |
| Free Cash Flow Yield | 0.57% |